Postnatal steroids: A dilemma for the neonatologist

Acta Paediatrica, International Journal of Paediatrics

Volumn 90, Issue 2, 2001, Pages 116-118

  Halliday, H L ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE; STEROID;

CEREBRAL PALSY; CHRONIC LUNG DISEASE; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG USE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NEWBORN CARE; NOTE; PRIORITY JOURNAL; RISK FACTOR; STEROID THERAPY;

EID: 0035100021     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/080352501300049145     Document Type: Note

References (18)

1. Budesonide delivered by dosimetric jet nebulization to preterm very low birthweight infants at high risk for development of chronic lung disease
2. The respiratory distress syndrome of the newborn. A report of 135 cases treated conservatively
3. A controlled trial of hydrocortisone therapy in infants with respiratory distress syndrome
4. Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia
5. Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia
6. Delayed (>3 weeks) postnatal corticosteroids to treat chronic lung disease in preterm infants
7. Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: A double-blind, controlled study
8. Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome
9. Early dexamethasone therapy in preterm infants: A follow-up study
10. Randomized placebo-controlled trial of a 42 day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birthweight infants: Outcome of study participants at 1-year adjusted age
11. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy
12. Postnatal dexamethasone in pre-term infants is potentially life-saving, but follow-up studies are urgently needed
13. Costs and benefits of perinatal corticosteroid treatment
14. Early postnatal (<96 h) corticosteroids for preventing chronic lung disease in preterm infants
15. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants
16. Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates
17. Early inhaled glucocorticoid therapy to prevent bronchopulmonary dysplasia
18. A multicenter randomized open study of early corticosteroid treatment (OSECT) in preterm babies with respiratory illness: Comparison of early and late treatment and of dexamethasone and inhaled budesonide